Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Mania Bipolar Disorder”

78 trials

Showing 20 of 78 results

Large-scale testing (Phase 3)Study completedNCT00145509
What this trial is testing

40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)

Who this might be right for
Bipolar Disorder
Organon and Co 77
Post-approval studies (Phase 4)Study completedNCT00277212
What this trial is testing

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,169
Not applicableStudy completedNCT00690248
What this trial is testing

Depressive Symptoms in Acute Manic Episode

Who this might be right for
Bipolar Disorder
AstraZeneca 250
Large-scale testing (Phase 3)Study completedNCT00299715
What this trial is testing

Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Large-scale testing (Phase 3)Study completedNCT01244815
What this trial is testing

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Who this might be right for
Bipolar Disorder, Pediatric
Organon and Co 404
Post-approval studies (Phase 4)Study completedNCT00350857
What this trial is testing

The Young Adult and Pediatric Bipolar Study

Who this might be right for
Bipolar I Disorder
Validus Pharmaceuticals 161
Large-scale testing (Phase 3)Study completedNCT00265330
What this trial is testing

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 169
Large-scale testing (Phase 3)Looking for participantsNCT06951711
What this trial is testing

Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Who this might be right for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb 274
Large-scale testing (Phase 3)Study completedNCT03257865
What this trial is testing

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder

Who this might be right for
Bipolar I DisorderManic Episode
Otsuka Pharmaceutical Development & Commercialization, Inc. 333
Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Large-scale testing (Phase 3)Study completedNCT00309699
What this trial is testing

Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 493
Post-approval studies (Phase 4)Ended earlyNCT00732251
What this trial is testing

Allopurinol Maintenance Study for Bipolar Disorder

Who this might be right for
Bipolar DisorderManiaMixed Mania
Cedars-Sinai Medical Center 15
Not applicableWithdrawnNCT01621165
What this trial is testing

Prazosin as an Antimanic Agent in Severe Mania or Mixed States

Who this might be right for
Bipolar, ManiaBipolar, Mixed State
Mclean Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Large-scale testing (Phase 3)WithdrawnNCT01124877
What this trial is testing

Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Large-scale testing (Phase 3)Study completedNCT06462612
What this trial is testing

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 351
Large-scale testing (Phase 3)Study completedNCT00606229
What this trial is testing

Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 41
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Large-scale testing (Phase 3)Study completedNCT00081380
What this trial is testing

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
AstraZeneca 710
Large-scale testing (Phase 3)Study completedNCT00606281
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 258
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation